Services

Protobios offers a range of MVA technology-driven services, including epitope mapping, antibody-targeted antigen profile analyses, and immunogenicity assessments, all tailored to meet the needs of the customers from applied research groups to the biotech industry. Kindly use the CONTACTS section for service inquiries.

PMID: 35246599 doi: 10.1038/s42003-022-03122-4

https://pubmed.ncbi.nlm.nih.gov/35246599/

PMID: 25424701  doi: 10.1007/s13277-014-2860-6

https://pubmed.ncbi.nlm.nih.gov/25424701/

PMID: 36207326  doi: 10.1038/s41598-022-20849-6

https://pubmed.ncbi.nlm.nih.gov/36207326/

PMID: 35603273 doi: 10.1038/s43856-022-00114-7

https://pubmed.ncbi.nlm.nih.gov/35603273/

PMID: 33996876 doi: 10.3389/fnut.2021.654008

https://pubmed.ncbi.nlm.nih.gov/33996876/

PMID: 39061399, doi: 10.3390/brainsci14070658; https://pubmed.ncbi.nlm.nih.gov/39061399/

PMID: 33493797 doi: 10.1016/j.ebiom.2021.103211

https://pubmed.ncbi.nlm.nih.gov/33493797/

PMID: 35091341 doi: 10.1016/j.ebiom.2022.103835

https://pubmed.ncbi.nlm.nih.gov/35091341/

PMID: 29449194 doi: 10.1016/j.ebiom.2018.01.043

https://pubmed.ncbi.nlm.nih.gov/29449194/

Defended PhD Thesis

Exploration of Host-Agent-Environment Interactions Using Tools of Metagenomic Sequencing and Next Generation Phage Display, 24.11.2023; https://doi.org/10.23658/taltech.56/2023

Immunodominant Antibody Epitopes Associated with the Development of Multiple Sclerosis and Type 1 Narcolepsy – A Next-Generation Phage-Display Analysis, 17.03.2022; https://doi.org/10.23658/taltech.5/2022